Pathological correlates of cognitive decline in Alzheimer's disease
- PMID: 18091671
Pathological correlates of cognitive decline in Alzheimer's disease
Abstract
Although Alzheimer's disease (AD) has been investigated for more than 100 years, it was not until the 60s that quantitative measures of the disease progression and severity in relation to function and neuropathology were made by Blessed and his colleagues. With the increasing understanding of the pathological changes of AD that take place, there is growing interest in identifying which pathological marker most reliably predicts the dementia and the cognitive profile. Markers of pathology that have been investigated include senile plaques, neurofibrillary tangles, synaptic loss, and neurochemical changes. Many clinical measures have been evaluated as well including Clinical Dementia Rating, Mini Mental State Examination, and Functional Assessment Staging as ways of both predicting the presence of pathological changes of AD as well as correlating with the specific measures of pathology. Accumulation of neuropathology appears to correlate with functional, global, and cognitive decline as people progress through AD. This review will summarize evidence of which neuropathological change correlates robustly with cognitive decline and which cognitive index predicts pathological changes in AD. In general, tangles and synaptic loss are better correlates of cognitive decline and correlate better.
Similar articles
-
Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology.J Intellect Disabil Res. 2007 Jun;51(Pt. 6):463-77. doi: 10.1111/j.1365-2788.2006.00902.x. J Intellect Disabil Res. 2007. PMID: 17493029
-
Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression.Arch Gen Psychiatry. 2006 Feb;63(2):161-7. doi: 10.1001/archpsyc.63.2.161. Arch Gen Psychiatry. 2006. PMID: 16461859
-
Morphological substrates of cognitive decline in nonagenarians and centenarians: a new paradigm?J Neurol Sci. 2007 Jun 15;257(1-2):72-9. doi: 10.1016/j.jns.2007.01.025. Epub 2007 Feb 15. J Neurol Sci. 2007. PMID: 17303173 Review.
-
[Alzheimer dementia. A clinical long-term study with quantitative neuropathology].Wien Med Wochenschr. 1991;141(20):455-62. Wien Med Wochenschr. 1991. PMID: 1763513 Review. German.
-
Diabetes is related to cerebral infarction but not to AD pathology in older persons.Neurology. 2006 Dec 12;67(11):1960-5. doi: 10.1212/01.wnl.0000247053.45483.4e. Neurology. 2006. PMID: 17159101
Cited by
-
Role of the Insulin-Like Growth Factor Type 1 Receptor in the Pathogenesis of Diabetic Encephalopathy.Int J Endocrinol. 2015;2015:626019. doi: 10.1155/2015/626019. Epub 2015 May 18. Int J Endocrinol. 2015. PMID: 26089889 Free PMC article.
-
The novel GLP-1/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD.Brain Behav. 2020 Mar;10(3):e01505. doi: 10.1002/brb3.1505. Epub 2020 Jan 20. Brain Behav. 2020. PMID: 31960630 Free PMC article.
-
Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory And Aging Project.Curr Alzheimer Res. 2011 Jun;8(4):336-40. doi: 10.2174/156720511795745302. Curr Alzheimer Res. 2011. PMID: 21222592 Free PMC article. Review.
-
Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD).Mol Neurodegener. 2011 Jan 11;6(1):3. doi: 10.1186/1750-1326-6-3. Mol Neurodegener. 2011. PMID: 21223591 Free PMC article.
-
Aβ toxicity in Alzheimer's disease.Mol Neurobiol. 2012 Apr;45(2):366-78. doi: 10.1007/s12035-012-8251-3. Epub 2012 Mar 14. Mol Neurobiol. 2012. PMID: 22415442 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical